Report Detail

Other Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2019-2025

  • RnM3841578
  • |
  • 04 December, 2019
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Screening Biomarker
      • 1.4.3 Diagnosis Biomarker
    • 1.5 Market by Application
      • 1.5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2025)
      • 1.5.2 Diagnostics
      • 1.5.3 Drug Discovery
      • 1.5.4 Personalized Medicine
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size
    • 2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Trends by Regions
      • 2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions (2019-2025)
      • 2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by by Players
      • 3.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by by Players (2014-2019)
      • 3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Area Served
    • 3.3 Key Players Prostate Specific Antigen (PSA) Blood Based Biomarker Product/Solution/Service
    • 3.4 Date of Enter into Prostate Specific Antigen (PSA) Blood Based Biomarker Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2014-2019)
    • 4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 5.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in North America
    • 5.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 5.4 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    6 Europe

    • 6.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 6.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Europe
    • 6.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 6.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    7 China

    • 7.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 7.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in China
    • 7.3 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 7.4 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    8 Japan

    • 8.1 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 8.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Japan
    • 8.3 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 8.4 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 9.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Southeast Asia
    • 9.3 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 9.4 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    10 India

    • 10.1 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 10.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in India
    • 10.3 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 10.4 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2014-2019)
    • 11.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Central & South America
    • 11.3 Central & South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
    • 11.4 Central & South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

    12 International Players Profiles

    • 12.1 ProteoMediX
      • 12.1.1 ProteoMediX Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.1.4 ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019))
      • 12.1.5 ProteoMediX Recent Development
    • 12.2 Cleveland Diagnostics
      • 12.2.1 Cleveland Diagnostics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.2.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.2.5 Cleveland Diagnostics Recent Development
    • 12.3 Randox
      • 12.3.1 Randox Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.3.4 Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.3.5 Randox Recent Development
    • 12.4 Roche
      • 12.4.1 Roche Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.4.5 Roche Recent Development
    • 12.5 GENFIT
      • 12.5.1 GENFIT Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.5.4 GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.5.5 GENFIT Recent Development
    • 12.6 Nutech Cancer Biomarkers
      • 12.6.1 Nutech Cancer Biomarkers Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.6.4 Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.6.5 Nutech Cancer Biomarkers Recent Development
    • 12.7 OGT (Sysmex Group)
      • 12.7.1 OGT (Sysmex Group) Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.7.4 OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.7.5 OGT (Sysmex Group) Recent Development
    • 12.8 Minomic
      • 12.8.1 Minomic Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.8.4 Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.8.5 Minomic Recent Development
    • 12.9 Creative Diagnostics
      • 12.9.1 Creative Diagnostics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
      • 12.9.4 Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2014-2019)
      • 12.9.5 Creative Diagnostics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Prostate Specific Antigen (PSA) Blood Based Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Specific Antigen (PSA) Blood Based Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      ProteoMediX
      Cleveland Diagnostics
      Randox
      Roche
      GENFIT
      Nutech Cancer Biomarkers
      OGT (Sysmex Group)
      Minomic
      Creative Diagnostics

      Market segment by Type, the product can be split into
      Screening Biomarker
      Diagnosis Biomarker

      Market segment by Application, split into
      Diagnostics
      Drug Discovery
      Personalized Medicine
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Prostate Specific Antigen (PSA) Blood Based Biomarker status, future forecast, growth opportunity, key market and key players.
      To present the Prostate Specific Antigen (PSA) Blood Based Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Prostate Specific Antigen (PSA) Blood Based Biomarker are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Prostate Specific Antigen (PSA) Blood Based Biomarker. Industry analysis & Market Report on Prostate Specific Antigen (PSA) Blood Based Biomarker is a syndicated market report, published as Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Prostate Specific Antigen (PSA) Blood Based Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,962.00
      4,442.99
      5,923.99
      3,514.85
      5,272.28
      7,029.70
      423,840.30
      635,760.45
      847,680.60
      276,265.47
      414,398.21
      552,530.94
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report